Dr. Andrew Auld, MD, PhD, MSc has about 20 years of experience in global public health in under-served settings in Africa, Southeast Asia, and the Caribbean. Since 2021, Dr. Auld has served as a Senior Disease Advisor within the HIV Team, as part of the COVID-19 Response Mechanism, at The Global Fund, Geneva. In this role, he serves as the HIV team focal point for laboratory and analytics, including analysis of COVID-19 interruptions and adaptations in global HIV programs.
From 2016 to 2021 he was the CDC Country Director in Malawi, where he supported the overall strategic direction for CDC Malawi, and facilitated increased funding levels from about $40 million/year in 2016 to over $100 million/year in 2021. During this time CDC Malawi supported the Ministry of Health and other stakeholders to accelerate towards HIV epidemic control, reaching 88-98-97 by 2021.
During 2009-2016, Dr. Auld served as a Medical Officer at CDC Atlanta, supporting global HIV and TB programs. He joined CDC as an Epidemic Intelligence Officer in 2007 and was awarded the Paul C. Schnitker award for extraordinary contributions to global public health by an EIS officer. Dr. Auld began his public health career with UNICEF in Indonesia following the 2004 Indian Ocean tsunami where he helped lead integrated health campaigns providing measles vaccinations, vitamin A, and insecticide-treated nets across several provinces in Sumatra.
Dr. Auld has received several public health awards including two first-author Charles C. Shepard Science awards from CDC in 2021, and the London School of Hygiene and Tropical Medicine Woodruff medal for the PhD thesis most likely to lead to alleviation of suffering in tropical or developing countries in 2020.
Dr. Auld is a licensed general medicine practitioner from South Africa (University of Cape Town) and the United Kingdom and has completed the United States Medical Licensure Exams (USMLE). In addition he has completed Master of Science and PhD degrees in Epidemiology through the London School of Hygiene and Tropical Medicine (LSHTM).